Mobile ODT / International Oncology

Results

• 150 patients enrolled in the pilot
• EVA allowed for improved workflow and documentation
• EVA reduced exam time and both patients and providers reported a more positive experience than VIA screenings 
• Providers reported it was much easier to use EVA for documenting patient information than existing methods (hand-written records or information typed on a laptop)
• Digitized data capture improved results documentation at the community level
• Information stored by the app allowed for much more rapid data analysis compared to naked-eye visualization. 
• The technology increased trust among patients because they were able to see images from their own exam
• EVA increased the patients’ sense of empowerment and ownership over their bodies

Lessons Learned

• MobileODT recognized how impactful technology such as the EVA can have in areas lacking healthcare infrastructure and resources, especially those with limited access to traditional cytology and biopsy services. 
• EVA improved documentation in screening camps where patient volumes and physical environments presented challenges. 
• Trials should separate providers using EVA from providers performing VIA, to better document the differences between the two methods.